Log in to save to my catalogue

T Lymphocyte Serotonin 5-HT[sub.7] Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosi...

T Lymphocyte Serotonin 5-HT[sub.7] Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A744349997

T Lymphocyte Serotonin 5-HT[sub.7] Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients

About this item

Full title

T Lymphocyte Serotonin 5-HT[sub.7] Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients

Publisher

MDPI AG

Journal title

Biomedicines, 2022-09, Vol.10 (10)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Serotonin (5-HT) is known as a potent immune cell modulator in autoimmune diseases and should be protective in the pathogenesis of multiple sclerosis (MS). Nevertheless, there is limited knowledge about receptors involved in 5-HT effects as well as induced mechanisms. Among 5-HT receptors, the 5-HT[sub.7] receptor is able to activate naïve T cells...

Alternative Titles

Full title

T Lymphocyte Serotonin 5-HT[sub.7] Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A744349997

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A744349997

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines10102418

How to access this item